Safety and Immunogenicity of Nanocovax, a SARS-CoV-2 Recombinant Spike Protein Vaccine
bioRxiv (2021) - Comments
doi: 10.1101/2021.07.22.21260942 

Thuy P. Nguyen, Quyet Do, Lan T Lan, Duc V. Dinh, Hiep Khong, Si Minh Do